Results 291 to 300 of about 367,441 (304)

Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional Mendelian randomization study

Frontiers in Immunology, 2023
Qin Jiading, Jin Chenghao
exaly  

Association of positive psychological well-being with circulating inflammatory markers: A systematic review and meta-analysis

Neuroscience and Biobehavioral Reviews, 2023
Jürgen Barth, Mary Princip, Roland Von Känel   +2 more
exaly  

Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology, 2016
, Hamed Khalili, Ashwin Ananthakrishnan   +2 more
exaly  

Circulating microRNA146b‐5p is superior to C‐reactive protein as a novel biomarker for monitoring inflammatory bowel disease

Alimentary Pharmacology and Therapeutics, 2019
Yao He, Minhu Chen, Peng Chen
exaly  

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

New England Journal of Medicine, 2004
Vilmundur Gudnason, Gideon Hirschfield, Gudny Eiríksdóttir   +2 more
exaly  

Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool

Cell, 2019
Jordi Ochando, Paolo Cravedi, Stefan Jordan   +2 more
exaly  

Circulating levels of inflammatory cytokines (IL-1β and TNF-α), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies

Thrombosis and Haemostasis, 2003
Yale S Arkel, De-Hui Ku, Michael Paidas   +2 more
exaly  

Impact of Archaic Introgression on the Abundance of Circulating Inflammatory Proteins in Modern Humans

Archaic introgression refers to the transfer of genetic material from archaic hominins such as Neanderthals into ancestors of modern humans. This admixture has left detectable introgressed variants in present-day human populations. Expanding studies suggest that these introgressed variants may affect the range of phenotypic traits, including immunity ...
openaire   +1 more source

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

Annals of Oncology, 2017
Fabrice André, Joseph Gligorov, Patrice Viens   +2 more
exaly  

Circulating tumor cells in metastatic inflammatory breast cancer

Annals of Oncology, 2009
, M Mego, U De Giorgi
exaly